1478629

Ondansetron Related Compound D

United States Pharmacopeia (USP) Reference Standard

• Sinônimo(s): 9-Methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one, 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one
• Fórmula empírica (Notação de Hill): C₁₄H₁₃NO
• Número CAS: 99614-64-9
• Peso molecular: 211.26
• Beilstein: 7920329
• Número MDL: MFCD08063682
• Código UNSPSC: 41116107
• ID de substância PubChem: 329750615
• NACRES: NA.24

Propriedades

• grau: pharmaceutical primary standard
• família API: ondansetron
• fabricante/nome comercial: USP
• aplicação(ões): pharmaceutical (small molecule)
• formato: neat
• cadeia de caracteres SMILES: Cn1c2CCC(=C)C(=O)c2c3ccccc13
• InChI: 1S/C14H13NO/c1-9-7-8-12-13(14(9)16)10-5-3-4-6-11(10)15(12)2/h3-6H,1,7-8H2,2H3
• chave InChI: AGQJDIDJKSFVTC-UHFFFAOYSA-N

Descrição

Descrição geral

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicação

Ondansetron Related Compound D USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:

• Ondansetron Oral Solution
• Ondansetron Injection
• Ondansetron
• Ondansetron Hydrochloride
• Ondansetron Orally Disintegrating Tablets

Nota de análise

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Outras notas

Sales restrictions may apply.